Detalles de la búsqueda
1.
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
N Engl J Med
; 390(7): 611-622, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38354140
2.
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection.
Antimicrob Agents Chemother
; : e0023624, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38780262
3.
Omadacycline for Community-Acquired Bacterial Pneumonia.
N Engl J Med
; 380(6): 517-527, 2019 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726692
4.
Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.
J Antimicrob Chemother
; 76(5): 1315-1322, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33458763
5.
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic.
Clin Infect Dis
; 69(Suppl 1): S40-S47, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31367740
6.
Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice.
Clin Infect Dis
; 69(Suppl 1): S33-S39, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31367741
7.
Omadacycline for Acute Bacterial Skin and Skin Structure Infections.
Clin Infect Dis
; 69(Suppl 1): S23-S32, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31367742
8.
Pancreatitis in tigecycline Phase 3 and 4 clinical studies.
J Antimicrob Chemother
; 69(3): 773-8, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24216769
9.
Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
J Infect Dis
; 208(11): 1813-20, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24092845
10.
Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.
Antimicrob Agents Chemother
; 57(4): 1756-62, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23357775
11.
Tigecycline does not prolong corrected QT intervals in healthy subjects.
Antimicrob Agents Chemother
; 57(4): 1895-901, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23403419
12.
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.
BMC Infect Dis
; 12: 297, 2012 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23145952
13.
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs.
Infect Dis Ther
; 11(1): 517-531, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015255
14.
The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study.
Eur J Drug Metab Pharmacokinet
; 46(1): 85-92, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33180250
15.
Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.
Open Forum Infect Dis
; 8(6): ofab136, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160473
16.
Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study.
Open Forum Infect Dis
; 8(6): ofab135, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160474
17.
Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment.
Int J Antimicrob Agents
; 57(2): 106263, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326848
18.
Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia.
Int J Infect Dis
; 104: 501-509, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33484864
19.
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.
Lancet Infect Dis
; 19(10): 1080-1090, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474458
20.
Patient-level data provide additional insight for tigecycline all-cause mortality meta-analysis.
Clin Infect Dis
; 55(12): 1739-40; author reply 1740-1, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22972861